202 related articles for article (PubMed ID: 36374108)
21. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription.
Chen Y; Hu J; Cai X; Huang Y; Zhou X; Tu Z; Hu J; Tavis JE; Tang N; Huang A; Hu Y
Antiviral Res; 2018 Jan; 149():16-25. PubMed ID: 29129707
[TBL] [Abstract][Full Text] [Related]
22. G
Yockteng-Melgar J; Shire K; Cheng AZ; Malik-Soni N; Harris RS; Frappier L
J Virol; 2022 Sep; 96(18):e0066022. PubMed ID: 36069545
[TBL] [Abstract][Full Text] [Related]
23. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
[TBL] [Abstract][Full Text] [Related]
24. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.
Lackey L; Law EK; Brown WL; Harris RS
Cell Cycle; 2013 Mar; 12(5):762-72. PubMed ID: 23388464
[TBL] [Abstract][Full Text] [Related]
25. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3B: pathological consequences of an innate immune DNA mutator.
Burns MB; Leonard B; Harris RS
Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
[TBL] [Abstract][Full Text] [Related]
27. Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.
Uriu K; Kosugi Y; Suzuki N; Ito J; Sato K
J Virol; 2021 May; 95(12):. PubMed ID: 33789992
[TBL] [Abstract][Full Text] [Related]
28. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.
Siriwardena SU; Perera MLW; Senevirathne V; Stewart J; Bhagwat AS
Mol Cell Biol; 2019 Jan; 39(1):. PubMed ID: 30348839
[TBL] [Abstract][Full Text] [Related]
29. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3B and AID have similar nuclear import mechanisms.
Lackey L; Demorest ZL; Land AM; Hultquist JF; Brown WL; Harris RS
J Mol Biol; 2012 Jun; 419(5):301-14. PubMed ID: 22446380
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of APOBEC3 enzymes by single-stranded DNAs containing 2'-deoxyzebularine.
Barzak FM; Harjes S; Kvach MV; Kurup HM; Jameson GB; Filichev VV; Harjes E
Org Biomol Chem; 2019 Nov; 17(43):9435-9441. PubMed ID: 31603457
[TBL] [Abstract][Full Text] [Related]
34. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.
Bandarra S; Miyagi E; Ribeiro AC; Gonçalves J; Strebel K; Barahona I
J Virol; 2021 Nov; 95(23):e0117021. PubMed ID: 34523960
[TBL] [Abstract][Full Text] [Related]
36. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo.
Naumann JA; Argyris PP; Carpenter MA; Gupta HB; Chen Y; Temiz NA; Zhou Y; Durfee C; Proehl J; Koniar BL; Conticello SG; Largaespada DA; Brown WL; Aihara H; Vogel RI; Harris RS
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298259
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
38. Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism.
Fanunza E; Cheng AZ; Auerbach AA; Stefanovska B; Moraes SN; Lokensgard JR; Biolatti M; Dell'Oste V; Bierle CJ; Bresnahan WA; Harris RS
bioRxiv; 2023 Jan; ():. PubMed ID: 36778493
[TBL] [Abstract][Full Text] [Related]
39. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.
Mahieux R; Suspène R; Delebecque F; Henry M; Schwartz O; Wain-Hobson S; Vartanian JP
J Gen Virol; 2005 Sep; 86(Pt 9):2489-2494. PubMed ID: 16099907
[TBL] [Abstract][Full Text] [Related]
40. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]